We would present this medicine in late spring. However, judging by its western counterparts, the medicine would be effective, Alexander Gintsburg said
Gamaleya Center starts testing its anti-COVID medicine based on monoclonal antibodies
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться